AD04 (ondansetron)
AD04-301
Phase 3 small_molecule completed
Quick answer
AD04 (ondansetron) for Alcohol Use Disorder is a Phase 3 program (small_molecule) at ADIAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADIAL PHARMACEUTICALS, INC.
- Indication
- Alcohol Use Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed